These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Immunohaematological findings in healthy and HIV-1 infected adults in Dar es Salaam, Tanzania.
    Author: Urassa WK, Lyamuya EF, Mbena E, Kagoma C, Bredberg Raden U, Pallangyo KP, Magessa P, Mhalu FS, Biberfeld G.
    Journal: East Afr Med J; 1996 Oct; 73(10):670-4. PubMed ID: 8997848.
    Abstract:
    In order to assess the prognostic value of lymphocyte subsets and immune activation markers in HIV-1 infected Tanzanian patients, peripheral white blood cell(WBC) count, total lymphocytes, CD4+ and CD8+ T-lymphocytes and Beta-2 microglobulin (B-2M) concentrations were determined among healthy HIV-1 seronegative Tanzanian blood donors and in infected Tanzania individuals in different clinical stages of HIV-1 infection. CD4+ T-lymphocytes, CD8+ T-lymphocyte percentages, CD4:CD8 lymphocyte ratios and the concentrations of B-2M were strongly correlated with the clinical stages of HIV-1 infection. These results suggest that B-2M could be a useful prognostic marker in HIV-1 infection in settings where T-lymphocyte subset determinations cannot be done. Lymphocyte subsets and concentrations of beta-2 microglobulin (B2M) were determined among 119 HIV-1 seronegative and 183 HIV-1 seropositive individuals at Muhimbili Medical Center (MMC) to assess their prognostic value in HIV-1 infected Tanzanian patients. The HIV-negative individuals were blood donors at MMC, while the HIV-positive participants were blood donors, patients admitted to one medical ward, and those seen at MMC's outpatient clinic who were found to be HIV-positive during the study period. HIV-negative blood donors were of mean age 28.8 years and patients were of mean age 33.5. The measurement of peripheral white blood cell (WBC) count, total lymphocytes, CD4 and CD8 T-lymphocytes, and B2M concentrations found CD4 T-lymphocytes, CD8 T-lymphocyte percentages, CD4:CD8 lymphocyte ratios, and the concentrations of B2M to be strongly correlated with the clinical stages of HIV-1 infection. These findings suggest that B2M could be a useful prognostic marker in HIV-1 infection in settings where T-lymphocyte subset determinations cannot be made.
    [Abstract] [Full Text] [Related] [New Search]